Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06565195
What this trial is testing

A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Prevail Therapeutics 124
Early research (Phase 1)Study completedNCT01211626
What this trial is testing

Study of ANA773 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) to Assess Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)

Who this might be right for
HCV Infection
Hoffmann-La Roche 75
Testing effectiveness (Phase 2)Study completedNCT04417972
What this trial is testing

The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis.

Who this might be right for
Endometriosis
Jiangsu HengRui Medicine Co., Ltd. 179
Testing effectiveness (Phase 2)Looking for participantsNCT06542250
What this trial is testing

Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Who this might be right for
B-cell Malignancies
AstraZeneca 174
Early research (Phase 1)Study completedNCT02524782
What this trial is testing

A Phase 1, Single- and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MEDI4166 in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
MedImmune LLC 103
Early research (Phase 1)Study completedNCT05795192
What this trial is testing

SB17170 Phase1 Trial in Healthy Volunteer

Who this might be right for
Safety IssuesTolerabilityPharmacokinetics+1 more
SPARK Biopharma 64
Early research (Phase 1)Looking for participantsNCT07760467
What this trial is testing

To Evaluate Safety, Tolerability, PK/PD & Food Effect of Single/Multiple Oral TUL321 Capsules in Healthy Participants.

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria, PNH
Zhuhai United Laboratories Co., Ltd. 94
Early research (Phase 1)Study completedNCT04007198
What this trial is testing

Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled Asthma

Who this might be right for
Asthma
Biocon Limited 18
Testing effectiveness (Phase 2)Ended earlyNCT05478031
What this trial is testing

A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
reMYND 14
Testing effectiveness (Phase 2)Ended earlyNCT03307512
What this trial is testing

PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD

Who this might be right for
Safety and Tolerability
Dance Biopharm Inc. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT07461181
What this trial is testing

Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Ruijin Hospital 10
Early research (Phase 1)Ended earlyNCT04045028
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaB-Cell Lymphoma
Genentech, Inc. 41
Testing effectiveness (Phase 2)Ended earlyNCT06365437
What this trial is testing

A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation

Who this might be right for
Kidney Transplantation
ITB-Med LLC 33
Early research (Phase 1)Study completedNCT01044537
What this trial is testing

A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 50
Early research (Phase 1)Active Not RecruitingNCT07551505
What this trial is testing

Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a)

Who this might be right for
Dyslipidemias
Bisirna Therapeutics (Suzhou) Co., Ltd. 40
Early research (Phase 1)Study completedNCT05496205
What this trial is testing

A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers

Who this might be right for
OsteoarthritisPainPost Herpetic Neuralgia+3 more
iN Therapeutics Co., Ltd. 104
Early research (Phase 1)Looking for participantsNCT06946641
What this trial is testing

A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients

Who this might be right for
Atopic DermatitisHidradenitis Suppurativa (HS)Rheumatoid Arthritis (RA)
Shanghai Qilu Pharmaceutical Research and Development Center LTD 102
Large-scale testing (Phase 3)Looking for participantsNCT04808505
What this trial is testing

Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18

Who this might be right for
Glycogen Storage Disease Type II Infantile Onset
Amicus Therapeutics 36
Testing effectiveness (Phase 2)Study completedNCT00834041
What this trial is testing

Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age

Who this might be right for
Hypertension
Novartis 39
Early research (Phase 1)Study completedNCT00949559
What this trial is testing

Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced Solid Tumors
Esperance Pharmaceuticals Inc 38
Next Page